MedPath

Effect of Phytosterol and Inulin-enriched Soymilk on LDL-cholesterol in Thai subjects

Not Applicable
Completed
Conditions
hypercholesterolemia
Phytosterol&#44
Inulin&#44
LDL&#45
c&#44
Lipid profile
Registration Number
TCTR20150417001
Lead Sponsor
Dairy Plus Company Limited.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
240
Inclusion Criteria

1) subjects who were 18 years old or older
2) subjects who had never used statin or were taking a stable dose of statin for at least 3 months and whose LDL-c levels were 130 mg/dl or higher

Exclusion Criteria

1) subjects who had established cardiovascular disease,
2) subjects who had any type of diabetes mellitus,
3) subjects who had gastrointestinal dysmotility,
4) subjects who had abnormal gastrointestinal digestion or absorption,
5) subjects who had an allergy to soymilk
6) subjects who had secondary hyperlipidemia such as hypothyroidism, nephrotic syndrome or hepatic disease

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
the LDL-c levels before and after consumption of the phytosterol and inulin enriched soymilk 8 weeks enzymatic in vitro assay for direct determination using a MODULAR P800 analyzer,the LDL-c levels in the study group and the control group 8 weeks enzymatic in vitro assay for direct determination using a MODULAR P800 analyzer
Secondary Outcome Measures
NameTimeMethod
total cholesterol, triglyceride and HDL-c levels in the study groups and control groups 8 weeks enzymatic in vitro assay for direct determination using a MODULAR P800 analyzer,adverse event rate in the study group and control group every visit (2 weeks) questionnaire, fasting plasma glucose, liver function test
© Copyright 2025. All Rights Reserved by MedPath